Xu Gao

Xu Gao

Auto-generated profile, based on publicly available information

Xu Gao

School of Chemical Engineering, Ocean and Life Sciences

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2025 in ACS Omega
Verified
Journal Article
Open access
ZZZhengyao Zhang
Zhengyao Zhang
ZLZhi Li
Zhi Li
YJYuhang Jin
Yuhang Jin
XGXu Gao
Xu Gao
ZZZekai Zhu
Zekai Zhu
BLBo Liu
Bo Liu
Colloidal gold immunochromatography has emerged as a pivotal platform for point-of-care diagnostics, yet challenges persist in stabilizing nanoparticle-antibody interactions and ensuring batch-to-batch reproducibility. To address these limitations, we engineered a nanogold-affinity peptide probe for the rapid detection of the lung cancer biomarker carcinoembryonic antigen (CEA), leveraging phage-display-derived peptides as biorecognition elements. The probe was synthesized by conjugating CEA-specific affinity peptides to polyethylene glycol (PEG)-functionalized gold nanoparticles (AuNPs) via covalent amide bonding, ensuring precise orientation and enhanced colloidal stability. Systematic optimization of reaction parameters, including the PEGylation time, peptide-to-nanoparticle ratios, and centrifugation conditions, yielded a robust preparation protocol. The resulting immunochromatographic test strip demonstrated a detection limit of 2.5 ng/mL for CEA, surpassing the clinical threshold of 5 ng/mL, and exhibited 91.7% accuracy in clinical serum samples. Notably, the substitution of antibodies with synthetic affinity peptides reduced costs by approximately 8-fold while maintaining high specificity and resistance to nonspecific binding. This work not only advances the integration of biomolecular engineering and nanotechnology for diagnostic applications but also establishes a scalable framework for developing stable, low-cost biosensors targeting macromolecular biomarkers.